MicroRNA-425-3p predicts response to sorafenib therapy in patients with hepatocellular carcinoma. - Wikidata - wikimedia - TriplyDB

MicroRNA-425-3p predicts response to sorafenib therapy in patients with hepatocellular carcinoma.

MicroRNA-425-3p predicts response to sorafenib therapy in patients with hepatocellular carcinoma.

http://www.wikidata.org/entity/Q53033550

about

First- and Second-Line Targeted Systemic Therapy in Hepatocellular Carcinoma-An Update on Patient Selection and Response Evaluation MiR-425-5p promotes invasion and metastasis of hepatocellular carcinoma cells through SCAI-mediated dysregulation of multiple signaling pathways A new mouse avatar model of non-small cell lung cancer.A Seven-microRNA Expression Signature Predicts Survival in Hepatocellular Carcinoma.Deregulation of MiR-34b/Sox2 Predicts Prostate Cancer Progression.The Contrasting Role of p16Ink4A Patterns of Expression in Neuroendocrine and Non-Neuroendocrine Lung Tumors: A Comprehensive Analysis with Clinicopathologic and Molecular Correlations pERK/pAkt phenotyping in circulating tumor cells as a biomarker for sorafenib efficacy in patients with advanced hepatocellular carcinoma.MicroRNA Expression Signatures Associated With BRAF-Mutated Versus KRAS-Mutated Colorectal Cancers.miR-494-3p is a novel tumor driver of lung carcinogenesis.miR-709 up-regulated in hepatocellular carcinoma, promotes proliferation and invasion by targeting GPC5.Non-Coding RNAs in Primary Liver Cancer.Cost effectiveness of regorafenib as second-line therapy for patients with advanced hepatocellular carcinoma.miR-363-5p as potential prognostic marker for hepatocellular carcinoma indicated by weighted co-expression network analysis of miRNAs and mRNA.PTK6 promotes hepatocellular carcinoma cell proliferation and invasion.Downregulation of miR-329 promotes cell invasion by regulating BRD4 and predicts poor prognosis in hepatocellular carcinoma.MicroRNA pharmacogenomics based integrated model of miR-17-92 cluster in sorafenib resistant HCC cells reveals a strategy to forestall drug resistance.MicroRNAs for the Prediction of Early Response to Sorafenib Treatment in Human Hepatocellular Carcinoma.Prognostic value of microRNAs in hepatocellular carcinoma: a meta-analysis.Analysis of microarrays of miR-34a and its identification of prospective target gene signature in hepatocellular carcinoma.New insights into the regulatory role of microRNA in tumor angiogenesis and clinical implications.Sorafenib response in hepatocellular carcinoma: MicroRNAs as tuning forks.Oncogenic miR-425-5p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma.Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and/or prognostic markers?

P2860

Q28073654-BE0F623F-2CF3-4397-BBA3-912E3DB75729 Q33761894-DF342AE8-2C56-4DDD-BC0C-10561AF79C43 Q35141122-00633C60-DDAF-413F-AB45-9BE4B2A0A00E Q35654057-4647765C-BDAA-4F47-A7F1-6DC262950111 Q35672901-3B41FCBD-CC16-4269-9F0B-9B7B102A50D0 Q35870560-73B1FC1C-8628-4D5E-9523-C09E8620E00F Q36771900-FD33DC09-FF87-4FC7-8DDF-3E5FF4369E59 Q36822387-F3FC78FA-1D9D-42CB-98C5-0311CC9237F5 Q37702495-0B3F81D5-6673-4571-8BFA-300084B9B434 Q38300178-533268E5-E127-4B54-8D93-328A6909CE60 Q38541359-0AD7F622-3CE9-4B21-B073-C91A6B706E35 Q38702281-9377F45B-E1A7-460F-835C-D8AB42EA874B Q38715236-5B0DE986-3D31-44B0-80B6-8EA72CD3D19E Q38731998-D00C5E0A-6555-4AB4-9BC0-0B69654EF23E Q38828743-714D7BE8-374B-45DC-8E34-F7ECB244F7A5 Q41126784-3D454FB5-7DFB-4399-8BDD-15123D27BB4D Q42317922-4EB8BE83-7EAB-40B2-87B5-C564BD3A9709 Q47096853-1C4C4640-0D49-46C9-ADBA-8A56E7CC0256 Q47247562-F6D19AF4-4C20-4C6B-8A10-BBA44C1186DF Q49800025-66160E70-FBDA-479D-831A-590737164FDA Q50063114-C43B02AB-C1EA-4483-99B0-F4644EBE0814 Q55618938-BFDF6773-4101-42DF-BA57-AD597E295620 Q57067866-2FCA1AD6-0218-4F81-8D50-2F571D453A3D

P2860

MicroRNA-425-3p predicts response to sorafenib therapy in patients with hepatocellular carcinoma.

http://www.wikidata.org/entity/Q53033550

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

MicroRNA-425-3p predicts respo ...... with hepatocellular carcinoma.

@en

MicroRNA-425-3p predicts respo ...... with hepatocellular carcinoma.

@nl

type

label

MicroRNA-425-3p predicts respo ...... with hepatocellular carcinoma.

@en

MicroRNA-425-3p predicts respo ...... with hepatocellular carcinoma.

@nl

prefLabel

MicroRNA-425-3p predicts respo ...... with hepatocellular carcinoma.

@en

MicroRNA-425-3p predicts respo ...... with hepatocellular carcinoma.

@nl

P1433

Q53033550-0C867CEC-2679-4236-ABB8-2F1B032E49C4

P1476

Q53033550-D30CC3C6-F882-48E0-9EEE-ECE521E3F0BC

P2093

Q53033550-01ADCD7F-C01A-487C-A2AF-ECA2F883CA6A

Q53033550-34ACBC96-F426-4524-886B-5E21D8D2D90D

Q53033550-5D1B421E-204F-4E90-96CA-DC1F6EEC33C6

Q53033550-6B563BB6-BDDD-49F5-ADD0-F83000522A12

Q53033550-7EED1581-2AC2-4C26-A9A3-D7403DC1F14A

Q53033550-B4F149EE-6867-4E69-A2D9-F67AFA5BA380

Q53033550-F4B25518-1B54-4360-82F6-9D70487BABBC

P2860

Q53033550-06F02998-BF78-40A3-9BDF-9DF8DB6EC7E0

Q53033550-0B69D77D-D488-4D83-9FA3-417436EA0ED8

Q53033550-127474E7-786A-4805-B252-A2BC22F0AB6F

Q53033550-1476CD7F-0B12-4343-A7FD-7D587B0C5315

Q53033550-1A62D817-0D80-41D4-9936-B982C8D445B5

Q53033550-1FD3C013-90CD-4E5B-A8A5-049C71FD9C03

Q53033550-21925C00-9DED-4029-966B-CA44FB62232E

Q53033550-22442769-B1C3-4C94-8D50-2900ED94170A

Q53033550-236BB7F9-88C3-468E-8596-7C1CB7568F0E

Q53033550-2806FAD5-4691-433F-BB25-7A329CD904CC

P304

Q53033550-74FFDF4C-C8B3-4C7C-8FBC-D478E7AD27E4

P31

Q53033550-86DFED1D-87AD-440D-B91B-6C1EB3198608

P356

Q53033550-8326ABF6-D990-4900-B1C5-E69DF3FB3967

P433

Q53033550-4F90CB71-7145-4AD6-A48D-11BBDFE9DC9D

P478

Q53033550-D0BF2D42-E6E5-425E-A9BE-7ABC52EC3DE5

P50

Q53033550-160E0B27-85ED-41A0-BA15-BFF0F2DA1081

Q53033550-2A4611E0-8EA8-48EB-96E4-43CFD553D381

Q53033550-4641A0DC-7488-4AFD-8A65-C52F451246D2

Q53033550-50E7D6C7-1844-456B-BA84-747CA284814E

Q53033550-5E911A00-A2E8-4F71-9BF6-85718E8D7D3C

Q53033550-79999630-D174-4574-BB44-0852FFB45140

Q53033550-B06822FD-AB82-49FA-A0F2-91D04E11A04A

Q53033550-CFCF427B-48B1-427F-B2B2-BDB99C1B0D04

Q53033550-FC351ED6-2A3D-482C-898E-6C585EC48BA1

P577

Q53033550-608196B5-42D5-430F-9194-725ADDEB7113

P5875

Q53033550-B0CEF490-10F9-4AE9-97BC-FD798A9C2102

P698

Q53033550-9FB420E0-09BF-4F24-A7EC-9969C7D889E9

P921

Q53033550-E25009AE-31B7-46BE-AC95-94AB5559E090

P356

P1433

Liver International

P1476

MicroRNA-425-3p predicts respo ...... with hepatocellular carcinoma.

@en

P2093

Carlo Carnaghi

http://www.w3.org/2001/XMLSchema#string

Claudia Augello

http://www.w3.org/2001/XMLSchema#string

Elena Rota Caremoli

http://www.w3.org/2001/XMLSchema#string

Gaia Spagnuolo

http://www.w3.org/2001/XMLSchema#string

Marco Maggioni

http://www.w3.org/2001/XMLSchema#string

Massimo Barberis

http://www.w3.org/2001/XMLSchema#string

Tiziana Pressiani

http://www.w3.org/2001/XMLSchema#string

P2860

MicroRNA expression, survival, and response to interferon in liver cancer

MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib

Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma

The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Sorafenib in advanced hepatocellular carcinoma

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

New data supporting modified RECIST (mRECIST) for Hepatocellular Carcinoma.

Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma.

Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer.

P304

1077-1086

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/LIV.12636

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P50

Massimo Roncalli

Lorenza Rimassa

Alice Faversani

Valentina Vaira

Roberto Labianca

Armando Santoro

Luca Di Tommaso

Stefano Fagiuoli

P577

2014-07-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263814034

http://www.w3.org/2001/XMLSchema#string

P698

25040368

http://www.w3.org/2001/XMLSchema#string

P921